VISIOPHARM A/S
Credit rating
Company information
About VISIOPHARM A/S
VISIOPHARM A/S (CVR number: 26186676) is a company from RUDERSDAL. The company reported a net sales of 35.7 mDKK in 2016. The operating profit percentage was poor at -1.8 % (EBIT: -0.6 mDKK), while net earnings were -628 kDKK. The profitability of the company measured by Return on Assets (ROA) was -3 %, which can be considered poor and Return on Equity (ROE) was -4.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 68.1 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. VISIOPHARM A/S's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | |
---|---|
Volume | |
Net sales | 35 670.00 |
Gross profit | 18 823.00 |
EBIT | - 639.00 |
Net earnings | - 628.00 |
Shareholders equity total | 13 214.00 |
Balance sheet total (assets) | 20 402.00 |
Net debt | -2 954.00 |
Profitability | |
EBIT-% | -1.8 % |
ROA | -3.0 % |
ROE | -4.8 % |
ROI | -4.4 % |
Economic value added (EVA) | - 474.34 |
Solvency | |
Equity ratio | 68.1 % |
Gearing | |
Relative net indebtedness % | 9.3 % |
Liquidity | |
Quick ratio | 1.9 |
Current ratio | 1.6 |
Cash and cash equivalents | 2 954.00 |
Capital use efficiency | |
Trade debtors turnover (days) | 56.5 |
Net working capital % | 10.7 % |
Credit risk | |
Credit rating | A |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.